A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Clinical trial NCT07743463 · RECRUITING

Trial details

NCT number: NCT07743463
Sponsor: Ascletis Pharma (China) Co., Limited
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Overweight Chronic Weight Management

Start date: 2026-08-01
Primary completion: 2028-07-01
Enrollment: 3003

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.